» Articles » PMID: 30338036

Isolation of Cancer Cells with Augmented Spheroid-forming Capability Using a Novel Tool Equipped with Removable Filter

Overview
Journal Oncotarget
Specialty Oncology
Date 2018 Oct 20
PMID 30338036
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Three-dimensional (3D) cell culture systems have been used to obtain multicellular spheroidal cell aggregates, or spheroids, from cancer cells. However, it is difficult to efficiently prepare large tumor-derived spheroids from cancer cells. To circumvent this problem, we here used a tool equipped with removal membrane, called Spheroid Catch, for the selection and enrichment of large-sized and/or size-matched spheroids from human squamous cell carcinoma (SAS cells) without loss of recovery. After a five-round process of selection and enrichment, we successfully isolated a subpopulation of SAS cells with augmented spheroid-forming capability, named eSAS: the efficiency of spheroid formation is 28.5% (eSAS) vs 16.8% (parental SAS). Notably, we found that some of eSAS cells survived after exposure of high doses of cisplatin in 3D culture. Moreover, orthotopic implantation by injecting eSAS cells into the tongues of nude mice showed reduced survival rate and increased tumor growth compared with those of nude mice injected with SAS cells. These results suggest that spheroids exhibiting properties of higher spheroid forming capacity can be efficiently collected by using Spheroid Catch. Indeed, genome-wide cDNA microarray and western blot analyses demonstrated higher mRNA and protein levels of hedgehog acyltransferase (HHAT), which is associated with stem maintenance in cell carcinoma by catalysing the N-palmitoylation of Hedgehog proteins, in eSAS cells than in SAS cells. We propose that Spheroid Catch could be useful for the study of spheroids, and potentially organoids, in the basic and clinical sciences, as an alternative method to other type of cell strainers.

Citing Articles

Palmitoylation of Hedgehog proteins by Hedgehog acyltransferase: roles in signalling and disease.

Resh M Open Biol. 2021; 11(3):200414.

PMID: 33653085 PMC: 8061759. DOI: 10.1098/rsob.200414.


LATS1/2 kinases trigger self-renewal of cancer stem cells in aggressive oral cancer.

Nozaki M, Yabuta N, Fukuzawa M, Mukai S, Okamoto A, Sasakura T Oncotarget. 2019; 10(10):1014-1030.

PMID: 30800215 PMC: 6383686. DOI: 10.18632/oncotarget.26583.

References
1.
Todoroki K, Ogasawara S, Akiba J, Nakayama M, Naito Y, Seki N . CD44v3+/CD24- cells possess cancer stem cell-like properties in human oral squamous cell carcinoma. Int J Oncol. 2015; 48(1):99-109. PMC: 4734600. DOI: 10.3892/ijo.2015.3261. View

2.
Chen S, Chang Y, Nieh S, Liu C, Yang C, Lin Y . Nonadhesive culture system as a model of rapid sphere formation with cancer stem cell properties. PLoS One. 2012; 7(2):e31864. PMC: 3281010. DOI: 10.1371/journal.pone.0031864. View

3.
Rodgers U, Lanyon-Hogg T, Masumoto N, Ritzefeld M, Burke R, Blagg J . Characterization of Hedgehog Acyltransferase Inhibitors Identifies a Small Molecule Probe for Hedgehog Signaling by Cancer Cells. ACS Chem Biol. 2016; 11(12):3256-3262. PMC: 5349656. DOI: 10.1021/acschembio.6b00896. View

4.
Matevossian A, Resh M . Hedgehog Acyltransferase as a target in estrogen receptor positive, HER2 amplified, and tamoxifen resistant breast cancer cells. Mol Cancer. 2015; 14:72. PMC: 4711017. DOI: 10.1186/s12943-015-0345-x. View

5.
Justilien V, Walsh M, Ali S, Thompson E, Murray N, Fields A . The PRKCI and SOX2 oncogenes are coamplified and cooperate to activate Hedgehog signaling in lung squamous cell carcinoma. Cancer Cell. 2014; 25(2):139-51. PMC: 3949484. DOI: 10.1016/j.ccr.2014.01.008. View